<p>Aytu Biopharma Inc. held its annual meeting of stockholders on December 10, 2025. All incumbent directors standing for reelection were elected by the stockholders. The appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ended June 30, 2026 was approved. An advisory vote regarding executive compensation was also approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aytu Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-037389), on December 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

AYTU

<p>Aytu Biopharma Inc. held its annual shareholder meeting on December 10, 2025. All incumbent directors were reelected, Grant Thornton LLP was appointed as the independent accounting firm for the fiscal year ending June 30, 2026, and an advisory vote on executive compensation was approved.</p>

Aytu Biopharma Inc. held annual shareholder meeting